Pay in 4 interest-free payments of $10.50 Learn more
Ships within 48 hours · Estimated delivery Nov 17 - Nov 22
is a potent autophagy inhibitor and TLR9 inhibitor
4-dioxobutan-2-yl)-3-((S)-2-(3-(tert-butyl)ureido)-3
Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors
5-a]pyrimidin-7-yl]phenyl]-N-methylacetamide
CUDC-101 - HDAC/EGFR/HER2 Inhibitor. CAS# 1012054-59-9 60129 is a potent autophagy inhibitorCUDC 101, CAS No. 1012054 59 9, is a potent multi target inhibitor targeting HDAC, EGFR and HER2 with IC50 of 4. 4 nM, 2. 4 nM, and 15. 7 nM, respectively. It is specific for class I and class II HDACs, not for class III Sir type HDACs, and has > 50 fold selectivity against other protein kinases. CUDC 101 displays broad antiproliferative activity in many human cancer cell types with IC50 of 0. 04 0. 80 M, exhibiting a higher potency than erlotinib,
US$ 147.50
US$ 163.00
US$ 155.50
US$ 150.00
US$ 219.50
US$ 177.00
US$ 145.00
US$ 191.00
US$ 149.00
US$ 17.00
US$ 109.00
US$ 154.50
US$ 112.50
US$ 145.50
US$ 153.50
US$ 154.50
US$ 176.00
US$ 163.00
US$ 137.00